Factors affecting the success of smoking cessation;Sigara bırakma başarısını etkileyen faktörler

Turk Toraks Dergisi

Volumn 14, Issue 3, 2013, Pages 81-87

  Argüder, Emine ^a   Karalezli, Ayşegül ^a   Hezer, Habibe ^a   Kiliç, Hatice ^a   Er, Mükremin ^a   Hasanoǧlu, Hatice Canan ^a   Demir, Pervin ^b  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Behavioural training; Bupropion; Nicotine replacement therapy (NRT); Smoking cessation; Varenicline

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

AGE; ARTICLE; COGNITIVE THERAPY; HUMAN; MAJOR CLINICAL STUDY; NICOTINE REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SMOKING; SMOKING CESSATION PROGRAM; TREATMENT OUTCOME;

EID: 84879716267     PISSN: 13027808     EISSN: 13085387     Source Type: Journal    
DOI: 10.5152/ttd.2013.18     Document Type: Article

References (45)

1. Karli{dotless}kaya C, Öztuna F, Solak ZA, ve ark. Tütün kontrolü. Toraks Dergisi 2006;7:51-64.
2. WHO. Report on the Global Tobacco Epidemic, 2011-MPOWER. Warning about the dangers of tobacco. Erişim tarihi: 05.01.2012. Available from: http://whqlibdoc.who.int/publications/ 2011/9789240687813_eng.pdf.
3. T.C. Saǧli{dotless}k Bakanli{dotless}ǧi{dotless} Temel Saǧli{dotless}k Hizmetleri Genel Müdürlüǧü. Küresel Yetişkin Tütün Araşti{dotless}rmasi{dotless} Türkiye Raporu 2010. Ulaşi{dotless}m linki: http://www.havanikoru.org.tr/dosya/Docs_Tutun_Dumaninin_Zararlari/ KYTA_Kitap_Tr.pdf
4. Küresel yetişkin tütün araşti{dotless}rmasi{dotless} 2008. Türkiye İstatistik Kurumu. Ulaşi{dotless}m linki: www.tuik.gov.tr/IcerikGetir.do?istab_id=215
5. Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. Am J Psychiatry 1996;153:1-31.
6. Treating tobacco use and dependence:2008 update. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2008.p.257.
7. Godtfredsen NS, Prescott E. Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. Clin Respir J 2011;5:187-94. [CrossRef]
8. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol 1992;11:331-4. [CrossRef]
9. Solak ZA, Telli CG, Erdinç E. Sigara bi{dotless}rakma tedavisinin sonuçlari{dotless}. Tur Toraks Derg 2003;4:73-7.
10. Uzaslan EK, Özyardi{dotless}mci{dotless} N, Karadaǧ M, et al. The physician's intervention in smoking cessation: Results of the five years of smoking cessation clinic. Ann Med Sci 2000;9:63-9.
11. Çan G, Öztuna F, Özlü T. Karadeniz Teknik Üniversitesi Ti{dotless}p Fakültesi sigara bi{dotless}rakma polikliniǧi sonuçlari{dotless}ni{dotless}n deǧerlendirilmesi. Tüberküloz ve Toraks Dergisi 2004;52:69-74.
12. Demir T, Tutluoǧlu B, Koç N, Bilgin L. Sigara bi{dotless}rakma polikliniǧimizin bir yi{dotless}lli{dotless}k izlem sonuçlari{dotless}. Tüberküloz ve Toraks Dergisi 2004;52:63-8.
13. Salepçi B, Fidan A, Oruç Ö, ve ark. Sigara bi{dotless}rakma polikliniǧimizde başari{dotless} oranlari{dotless} ve başari{dotless}da etkili faktörler. Tur Toraks Derg 2005;6:151-8.
14. Raherison C, Marjary A, Valpromy B, et al. Evaluation of smoking cessation success in adults. Respir Med 2005;99:1303-10. [CrossRef]
15. Tillgren P, Haglund BJ, Lundberg M, Romelsjo A. The sociodemographic patern of tobacco cessation in the 980s: results from a panel study of living condition surveys in Sweden. J Epidemiol Community Health 1996;50:625-30. [CrossRef]
16. Renaud JM, Halpern MT. Clinical management of smoking cessation: patient factors affecting a reward-based approach. Patient Prefer Adherence 2010;4:441-50.
17. Saǧlam L. Investigation of the results of a smoking cessation clinic and the factors associated with succes. Turk J Med Sci 2012;42:515-22.
18. Etter JF, Duc TV, Perneger TV. Validity of the Fagerstrom test for nicotine dependence and of the heaviness of smoking index among relatively light smokers. Addiction 1999;94:269-81. [CrossRef]
19. Onen ZP, Sen E, Eriş Gülbay B, ve ark. Comparing the effectiveness of different treatment modalities on the smoking cessation rates. Tuberk Toraks 2010;58:385-92.
20. Önen ZP, Şen E, Gülbay BE, ve ark. Kronik Obstrüktif Akciǧer Hastali{dotless}ǧi{dotless} ve asti{dotless}m olgulari{dotless}nda uzun dönem sigara bi{dotless}rakma oranlari{dotless} ve iki grup arasi{dotless}ndaki farkli{dotless}li{dotless}klar. Tur Toraks Derg 2011;12:67-71.
21. Solak ZA, Başoǧlu ÖK, Erdinç E. Kronik obstrüktif akciǧer hastali{dotless}ǧi{dotless} olgulari{dotless}nda sigarayi{dotless} bi{dotless}rakma başari{dotless}si{dotless}. Tüberküloz ve Toraks Dergisi 2006;54:43-50.
22. Solak ZA, Göksel T, Erdinç E, ve ark. Sigara ile ilişkili ciddi akciǧer hastali{dotless}ǧi{dotless} olanlari{dotless}n sigara içen yaki{dotless}nlari{dotless}nda sigara bi{dotless}rakma tedavisinin başari{dotless}si{dotless}. Tur Toraks Derg 2002;3:248-52.
23. Office for National Statistics. Smoking-related behaviour and attitudes.
24. www.statistics.gov.uk/downloads/theme_health/Smoking2005. pdf
25. Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006;8:739-49. [CrossRef]
26. McEwen A, West R. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services. BMC Public Health 2009;9:28. [CrossRef]
27. Prochaska JO, DiClemente CC, Velicer WF, et al. Predicting change in smoking status for self-changers. Addict Behav 1985;10:395-406. [CrossRef]
28. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004;29:1067-83. [CrossRef]
29. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005:CD001007.
30. Bakkevic O, Steine S, von Hafenbradl K, et al. Smoking cessation. A comparative, randomised study between management in general practice and the behavioural programme SmokEnders. Scand J Prim Health Care 2000;18:247-51. [CrossRef]
31. Aytemur ZA, Pişmişoǧlu B, Ki{dotless}li{dotless}nç O, et al. Intensive clinic intervention plus psychodrama in smoking cessation and effects on cessation outcome. Turkiye Klinikleri J Med Sci 2012;32:630-7. [CrossRef]
32. Slama K, Redman S, Perkins J, et al. The effectiveness of two smoking cessation programs for use in general practice. A randomized clinical trial. BMJ 1990;300:1707-9. [CrossRef]
33. Örsel O, Örsel S, Alpar S, ve ark. Sigarayi{dotless} bi{dotless}rakmada nikotin replasman tedavisi ve davrani{dotless}ş eǧitimi yöntemlerinin karşi{dotless}laşti{dotless}ri{dotless}lmasi{dotless}: Doǧal izlem çali{dotless}şmasi{dotless}. Tüberküloz ve Toraks Dergisi 2005;53:354-61.
34. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008:1:CD000146.
35. Foll LB, Cheinin MP, Rostoker G, et al. Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. European Pychiatry 2005;20:431-41. [CrossRef]
36. Campbell IA, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med 1996;90:47-51. [CrossRef]
37. Kralikova E, Kozak JT, Rasmussen T, et al. Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health 2009;9:433. [CrossRef]
38. Şahbaz S, Ki{dotless}li{dotless}nç O. Sigara bi{dotless}rakmada kullani{dotless}lan tedavi töntemleri. Sted 2005;14:98-102.
39. Hurt RD, Sachs DPL, Glover ED, Offord KP. A comparison of sustained-release bupropion and placebo for smoking cessation. The New England J of Med 1997;337:1195-202. [CrossRef]
40. Sheng LX, Tang YL, Jiang ZN, et al. Sustained-release bupropion for smoking cessation in a chinese sample: a double-blind, placebo-controlled, randomized trial. Nicotine Tob Res 2013;15:320-5. [CrossRef]
41. Hughes JR. Comorbidity and smoking. Nicotine Tob Res 1999;1:149-66. [CrossRef]
42. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults--United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:1157-61.
43. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009;31:463-91. [CrossRef]
44. Tashkin DP, Rennard S, Hays JT, et al. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest 2011;139:591-9. [CrossRef]
45. Blak BT, Wilson K, Metcalfe M, et al. Evaluation of varenicline as an aid to smoking cessation in UK general practice-a THIN database study. Curr Med Res Opin 2010;26:861-70. [CrossRef]